Ampio pharmaceuticals, inc. (AMPE)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net (loss) income

-5,179

-1,019

-7,219

421

-5,812

1,525

5,801

4,620

22,039

-43,126

-4,252

-2,608

-1,904

-3,354

-3,992

-5,052

-6,764

-10,622

-7,786

-7,713

-7,591

-10,152

-9,491

-8,932

-10,471

Adjustments to reconcile net (loss) income to net cash used in operating activities
Stock-based compensation, net

213

58

246

72

28

156

95

72

119

61

306

171

205

153

443

273

646

1,299

872

1,640

1,144

2,052

2,497

1,605

1,021

Depreciation and amortization

295

296

239

371

365

312

346

320

300

303

303

303

303

297

305

305

305

206

205

205

206

-

-

41

41

Write-off of advances to stockholder

-

-

-

-

-

-

-

-

-

0

0

0

25

0

0

0

0

-

-

-

-

-

-

-

-

Amortization of prepaid research and development - related party (Note 9)

-

-

-

-

-

-

-

-

-

0

0

287

35

35

35

35

35

35

35

35

35

-30

66

66

11

Issuance of common stock for services

80

20

0

0

60

0

0

0

60

0

0

0

60

0

0

0

60

0

0

0

30

0

0

0

30

Derivative loss (gain)

831

6,101

-2,054

3,981

-3,160

4,187

7,744

7,751

25,614

-38,311

-1,146

2,113

1,126

-199

-715

0

0

-

-

-

-

-

-

-

-

Loss on equity investment in Aytu BioSciences, Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-690

-352

-

-

-

-

-

-

-

-

Unrealized loss on trading security in Aytu BioScience, Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-30

-210

64

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities
(Increase) decrease in prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-200

577

-418

-

-

657

363

Increase in prepaid expenses and other

-698

-118

173

1,035

180

-99

194

-69

152

-209

-320

166

234

-130

-228

205

72

-

-

-

-

-

-

-

-

Increase (decrease) in accounts payable and accrued expenses

189

1,894

249

560

-5

-340

-1,544

-317

-292

1,757

-799

1,061

56

-437

-222

-841

406

-

-

-

-

-

-

-

-

Decrease in lease liability

-18

-18

62

-58

-56

-16

-15

-15

-13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in prepaid research and development - related party (Note 11)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-300

450

-1,340

Decrease in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11

316

-2,017

-

-24

-2,323

2,521

Increase in accrued liabilities - related party (Note 7)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

600

Decrease in deferred rent

-

-

-

-

-

-

-

-

-

13

13

12

11

11

11

10

8

8

8

7

6

-

-

-

-

(Decrease) increase in deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-21

228

-12

Increase (decrease) in accrued compensation

-

-

-

-

-

-

-

4

-50

-151

-78

-41

-61

159

22

142

155

62

85

298

297

141

-37

37

-522

Net cash used in operating activities - continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,788

-6,405

-5,800

-7,482

1,595

-6,757

-9,733

-8,484

Net cash used in operating activities - discontinuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,554

158

375

476

-

-

-

-

Net cash used in operating activities

-4,553

-4,751

-4,737

-3,453

-2,440

-2,326

-3,210

-2,998

-3,604

-2,571

-3,129

-3,085

-2,621

-

-

-

-4,883

-7,765

-6,247

-5,425

-7,006

-

-

-

-

Cash flows used in investing activities
Purchase of fixed assets

0

7

0

8

5

78

43

253

188

38

15

0

17

6

0

0

0

1

24

41

43

743

2,026

2,856

3,042

Net cash used in investing activities - continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,180

-24

-41

-43

-6,264

-2,013

-2,856

-3,042

Net cash used in investing activities - discontinuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-780

-3

-1,002

0

-

-

-

-

Net cash used in investing activities

0

-7

-0

-8

-5

-78

-43

-253

-188

-38

-15

0

-17

-

-

-

0

-16,961

-27

-1,044

-43

-

-

-

-

Cash flows from financing activities
Proceeds from sale of common stock in connection with the equity distribution agreement

682

-0

0

142

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs related to sale of common stock in connection with the equity distribution agreement

246

-0

0

144

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-33

0

68,442

Costs related to sale of common stock related to the confidentially marketed public offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

4,999

Proceeds from warrant exercises

0

3,524

0

330

20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from option and warrant exercises

-

-

-

-

-

-

-

-

3,100

2,806

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities - continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-33

0

63,442

Net cash provided by financing activities - discontinuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,271

4,876

-18

0

-

-

-

-

Net cash provided by financing activities

436

3,247

-0

11,084

20

1,317

7,264

395

3,100

9,012

12

5,769

0

-

-

-

0

16,300

4,876

-18

0

-

-

-

-

Net change in cash and cash equivalents

-4,117

-1,511

-4,738

7,622

-2,425

-1,086

4,011

-2,856

-691

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

-

6,401

-3,133

2,683

-2,638

-2,522

965

-4,662

-4,883

-8,426

-1,398

-6,488

-7,049

-6,509

-8,804

-12,590

51,916

Non-cash transactions:
Initial lease liability arising from the adoption of ASU 2016-02

0

-0

0

0

1,704

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Initial recognition of right-of-use asset arising from the adoption of ASU 2016-02

0

0

0

-0

1,168

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fixed asset purchases included in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-19

44

-

-

-

-

Distribution to stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

13,018

-

-

-

-

-

-

-

-